You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced melanoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Monitoring T Cell Responses in Melanoma, Lung and Other Cancer

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +9 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Oct 4, 2023

Melanoma Trial in Washington, Baltimore, Hackensack (Nivolumab, Ipilimumab, Cabozantinib)

Suspended
  • Melanoma
  • Washington, District of Columbia
  • +2 more
Jan 18, 2023

Melanoma Trial (Dapansutrile, Pembrolizumab)

Not yet recruiting
  • Melanoma
  • (no location specified)
Jul 26, 2022

Advanced Melanoma in Germany Using a German Database

Completed
  • Advanced Melanoma
    • Frankfurt, Germany
      Site0001
    Jun 16, 2022

    Metastatic Melanoma, Skin Cancer, Tumor Trial in New York (ADI PEG 20)

    Completed
    Has Results
    • Metastatic Melanoma
    • +2 more
    • ADI PEG 20
    • New York, New York
    • +1 more
    Oct 3, 2022

    Melanoma Trial in Germany (Lipo-MERIT)

    Active, not recruiting
    • Melanoma
    • Lipo-MERIT
    • Frankfurt, Germany
    • +3 more
    Jan 5, 2023

    NSCLC, Melanoma Trial (IMM60, Pembrolizumab)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Melanoma
    • (no location specified)
    Jan 24, 2023

    Advanced Melanoma Trial in United States (FLX475, Ipilimumab)

    Recruiting
    • Advanced Melanoma
    • Los Angeles, California
    • +3 more
    Jun 10, 2022

    Advanced Melanoma Trial (DCB-BO1301)

    Not yet recruiting
    • Advanced Melanoma
    • (no location specified)
    Mar 17, 2022

    Melanoma Stage III, Melanoma Stage IV Trial in Jette (Regorafenib 40 MG Oral Tablet)

    Not yet recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • Regorafenib 40 MG Oral Tablet
    • Jette, Brussel, Belgium
      UZ Brussels
    May 6, 2022

    Response and Resistance to Pembrolizumab in Melanoma

    Recruiting
    • Melanoma
    • Advanced Melanoma
    • Biopsy
    • Biospecimen Collection
    • San Francisco, California
      University of California, San Francisco
    Nov 17, 2022

    Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

    Not yet recruiting
    • Metastatic Melanoma
    • Skin Cancer
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Mar 9, 2023

    Melanoma Trial in BeiJing (TQB2618 injection, Terprizumab injection)

    Not yet recruiting
    • Melanoma
    • TQB2618 injection
    • Terprizumab injection
    • BeiJing, Beijing, China
      Peking University Cancer Hospital
    Jul 8, 2022

    Melanoma Trial in United States (CAVATAK, Ipilimumab)

    Completed
    • Melanoma
    • Duarte, California
    • +10 more
    Jan 12, 2023

    Metastatic Melanoma, Unresectable Melanoma, Melanoma Trial (Lifileucel plus Pembrolizumab, Pembrolizumab with Optional Crossover

    Not yet recruiting
    • Metastatic Melanoma
    • +2 more
    • Lifileucel plus Pembrolizumab
    • Pembrolizumab with Optional Crossover Period
    • (no location specified)
    Feb 13, 2023

    Melanoma (Skin) Trial in Omsk, Saint Petersburg (BCD-201, Keytruda)

    Recruiting
    • Melanoma (Skin)
    • Omsk, Russian Federation
    • +2 more
    Aug 1, 2023

    Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

    Not yet recruiting
    • Locally Advanced Alveolar Soft Part Sarcoma
    • +9 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 10, 2023

    Advanced Melanoma Trial in China (LBL-007, Toripalimab, Axitinib Tablets)

    Recruiting
    • Advanced Melanoma
    • Beijing, Beijing, China
    • +7 more
    Jan 9, 2023

    Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV Trial in Iowa City, Rochester, Madison ([212Pb]VMT01)

    Not yet recruiting
    • Melanoma (Skin)
    • +5 more
    • Iowa City, Iowa
    • +2 more
    Dec 8, 2022

    Advanced Melanoma Trial in China (HLX208)

    Recruiting
    • Advanced Melanoma
    • Peking, Beijing, China
    • +6 more
    May 1, 2022

    Advanced Melanoma Trial in Pittsburgh (Pembrolizumab Injection [Keytruda], Metformin)

    Recruiting
    • Advanced Melanoma
    • Pittsburgh, Pennsylvania
      Univ of Pittsburgh Medical Center Hillman Cancer Center
    Jan 24, 2022

    Metastatic Melanoma, Advanced Melanoma Trial in San Francisco (XmAb22841, XmAb23104)

    Not yet recruiting
    • Metastatic Melanoma
    • Advanced Melanoma
    • San Francisco, California
      University of California, San Francisco
    Jan 13, 2023

    Melanoma Trial in Beijing (HL-085, Vemurafenib)

    Recruiting
    • Melanoma
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Apr 10, 2022

    Advanced Melanoma, Hepatitis B, Hepatitis C Trial in Taipei 105

    Completed
    • Advanced Melanoma
    • +2 more
      • Taipei 105, Taiwan
        Local Institution
      Jan 11, 2022

      Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento

      Recruiting
      • Advanced Colorectal Carcinoma
      • +15 more
      • Fermented Wheat Germ Extract
      • Sacramento, California
        University of California Davis Comprehensive Cancer Center
      Jul 26, 2023